McIntyreTM, ModurV, PrescottSM, ZimmermanGA. Molecular mechanisms of early inflammation. Thromb Haemost1997;78:302–305.
2.
PrescottSM, McIntyreTM, ZimmermanGA. Platelet-activating factor: A phospholipid mediator of inflammation. In:GallinJI, SnydermanR, eds.Inflammation: Basic Principles and Clinical Correlates. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 1999:387–389.
3.
ZimmermanGA, McIntyreTM, PrescottSM. Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. J Clin Invest1985;76:2235–2246.
4.
ZimmermanGA, McIntyreTM, PrescottSM. Adhesion and signaling in vascular cell-cell interactions. J Clin Invest1996;98:1699–1702.
5.
ZimmermanGA, PrescottSM, McIntyreTM. Endothelial cell interactions with granulocytes: Tethering and signaling molecules. Immunol Today1992;13:93–100.
MayadasTN, JohnsonRC, RayburnH, HynesRO, WagnerDD. Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell1993;74:541–554.
11.
PrescottSM, ZimmermanGA, McIntyreTM. Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin. Proc Natl Acad Sci U S A1984;81:3534–3538.
12.
CamussiG, AgliettaM, MalavasiF, TettaC, PiacibelloW, SanavioF, BussolinoF. The release of platelet-activating factor from human endothelial cells in culture. J Immunol1983;131:2397–2403.
13.
ZimmermanGA, PrescottSM, McIntyreTM. Platelet-activating factor: A fluid-phase and cell-mediator of inflammation. In:GallinJI, GoldsteinIM, eds.Inflammation: Basic Principles and Clinical Correlates. 2nd ed. New York: Raven Press; 1992:149–176.
14.
HondaZ, NakamuraM, MikiI, MinamiM, WatanabeT, SeyamaY, OkadoH, TohH, ItoK, MiyamotoT, . Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature1991;349:342–346.
15.
NakamuraM, HondaZ, IzumiT, SakanakaC, MutohH, MinamiM, BitoH, SeyamaY, MatsumotoT, NomaM, . Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. J Biol Chem1991;266:20400–20405.
16.
KunzD, GerardNP, GerardC. The human leukocyte platelet-activating factor receptor. cDNA cloning, cell surface expression, and construction of a novel epitope-bearing analog. J Biol Chem1992;267:9101–9106.
17.
YeRD, ProssnitzER, ZouA, CochraneCG. Characterization of a human cDNA that encodes a functional receptor for platelet activating factor. Biochem Biophys Res Commun1991;180:105–111.
18.
LorantDE, PatelKD, McIntyreTM, McEverRP, PrescottSM, ZimmermanGA. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: A juxtacrine system for adhesion and activation of neutrophils. J Cell Biol1991;115:223–234.
19.
ShuklaSD. Platelet-activating factor receptor and signal transduction mechanisms. FASEB J1992;6:2296–22301.
20.
AliH, RichardsonRM, TomhaveED, DuBoseRA, HaribabuB, SnydermanR. Regulation of stably transfected platelet-activating factor receptor in RBL-2H3 cells. J Biol Chem1994;269:24557–24563.
21.
CarlsonSA, ChatterjeeTK, FisherRA. The third intracellular domain of the platelet-activating factor receptor is a critical determinant in receptor coupling to phosphoinositide phospholipase C-activating G proteins. Studies using intracellular domain minigenes and receptor chimeras. J Biol Chem1996;271:23146–23153.
22.
WhatleyRE, ZimmermanGA, PrescottSM, McIntyreTM. Platelet-activating factor and PAF-like mimetics. In:BellRM, ExtonJH, PrescottSM, eds.Lipid Second Messengers. Handbooks of Lipid Research, Vol. 8. New York: Plenum Press; 1996:239–276.
23.
WeyrichAS, McIntyreTM, McEverRP, PrescottSM, ZimmermanGA. Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion: Signal integration and NF-κB translocation. J Clin Invest1995;95:2297–2303.
24.
ImaizumiT, AlbertineKH, JichaDL, McIntyreTM, PrescottSM, ZimmermanGA. Human endothelial cells synthesize and secrete ENA-78: Relationship to IL-8 and to signaling of PMN adhesion. Am J Respir Cell Mol Biol1997;17:181–192.
25.
Ben-BaruchA, MichielDF, OppenheimJJ. Signals and receptors involved in recruitment of inflammatory cells. J Biol Chem1995;270:11703–11706.
26.
PatelKD, ZimmermanGA, PrescottSM, McEverRP, McIntyreTM. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J Cell Biol1991;112:749–759.
27.
PatelKD, ZimmermanGA, PrescottSM, McIntyreTM. Novel leukocyte agonists are released by endothelial cells exposed to peroxide. J Biol Chem1992;267:15168–15175.
28.
LehrHA, WeyrichAS, SaetzlerRK, JurekA, ArforsKE, ZimmermanGA, PrescottSM, McIntyreTM. Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking. J Clin Invest1997;99:2358–2364.
29.
KubesP, SuzukiM, GrangerDN. Modulation of PAF-induced leukocyte adherence and increased microvascular permeability. Am J Physiol1990;259:G859–G864.
30.
HirashimaY, EndoS, OhmoriT, KatoR, TakakuA. Platelet-activating factor (PAF) concentration and PAF acetylhydrolase activity in cerebrospinal fluid of patients with subarachnoid hemorrhage. J Neurosurg1994;80:31–36.
31.
SatohK, ImaizumiT-a, YoshidaH, HiramotoM, TakamatsuS. Increased levels of blood platelet-activating factor (PAF) and PAF-like lipids in patients with ischemic stroke. Acta Neurol Scand1992;85:122–127.
32.
HsiehK-H, NgC-K. Increased plasma platelet-activating factor in children with acute asthmatic attacks and decreased in vivo and in vitro production of platelet-activating factor after immunotherapy. J Allergy Clin Immunol1993;91:650–657.
33.
MaratheGK, DaviesSS, HarrisonKA, SilvaAR, MurphyRC, Castro-Faria-NetoH, PrescottSM, ZimmermanGA, McIntyreTM. Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines. J Biol Chem1999;274:28395–28404.
34.
ChiltonFH, EllisJM, OlsonSC, WykleRL. 1-0-Alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine: A common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes. J Biol Chem1984;259:12014–12019.
35.
DomenechC, Machado-De DomenechE, SolingHD. Regulation of acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine O2-acetyltransferase (lyso-PAF-acetyltransferase) in exocrine glands: Evidence for an activation via phosphorylation by calcium/calmodulin-dependent protein kinase. J Biol Chem1987;262:5671–5676.
36.
HollandMR, VenableME, WhatleyRE, ZimmermanGA, McIntyreTM, PrescottSM. Activation of the acetyl-coenzyme A: Lysoplatelet-activating factor acetyltransferase regulates platelet-activating factor synthesis in human endothelial cells. J Biol Chem1992;267:22883–22890.
37.
LenihanDJ, LeeTC. Regulation of platelet-activating factor synthesis: Modulation of 1-alkyl-2-lyso-sn-glycero-3-phosphocholine:acetyl-CoA acetyltransferase by phosphorylation and dephosphorylation in rat spleen microsomes. Biochem Biophys Res Commun1984;120:834–839.
38.
NietoML, VelascoS, Sanchez CrespoM. Modulation of acetyl-CoA:1-alkyl-2-lyso-sn-glycero-3-phosphocholine (lyso-PAF) acetyltransferase in human polymorphonuclears: The role of cyclic AMP-dependent and phospholipid sensitive, calcium-dependent protein kinases. J Biol Chem1988;263:4607–4611.
39.
TjoelkerLW, WilderC, EberhardtC, StafforiniDM, DietschG, SchimpfB, HooperS, Le TrongH, CousensLS, ZimmermanGA, . Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature1995;374:549–553.
MiwaM, MiyakeT, YamanakaT, SugataniJ, SuzukiY, SakataS, ArakiY, MatsumotoM. Characterization of serum platelet-activating factor (PAF) acetylhydrolase: Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. J Clin Invest1988;82:1983–1991.
43.
StafforiniDM, SatohK, AtkinsonDL, TjoelkerLW, EberhardtC, YoshidaH, ImaizumiT, TakamatsuS, ZimmermanGA, McIntyreTM, GrayPW, PrescottSM. Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase. J Clin Invest1996;97:2784–2791.
44.
HiramotoM, YoshidaH, ImaizumiT, YoshimizuN, SatohK. A mutation in plasma platelet-activating factor acetylhydrolase (Val279>Phe) is a genetic risk factor for stroke. Stroke1997;28:2417–2420.
45.
YamadaY, IchiharaS, FujimuraT, YokotaM. Identification of the G994>T missense in exon 9 of the plasma platelet-activating factor acetylhydrolase gene as an independent risk factor for coronary artery disease in Japanese men. Metabolism1998;47:177–181.
46.
IchiharaS, YamadaY, YokotaM. Association of a G994>T missense mutation in the plasma platelet-activating factor acetylhydrolase gene with genetic susceptibility to nonfamilial dilated cardiomyopathy in Japanese. Circulation1998;98:1881–1885.
47.
StafforiniDM, NumaoT, TsodikovA, VaitkusD, FukudaT, WatanabeN, FuekiN, McIntyreTM, ZimmermanGA, MakinoS, PrescottSM. Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma. J Clin Invest1999;103:989–997.
48.
HenriquesMG, RaeGA, CordeiroRS, WilliamsTJ. Endothelin-1 inhibits PAF-induced paw oedema and pleurisy in the mouse. Br J Pharmacol1992;106:579–582.